Download your application note on TGF-β/SMAD/α-SMA signaling in NASH


Discover the benefits of using HTRF assays to characterize liver fibrosis.

Several molecular markers have been investigated as possible factors in the progression of non-alcoholic steatohepatitis (NASH) towards liver fibrosis.

The TGF-b/SMAD/α-SMA pathway has a crucial role in this progression and has emerged as an important therapeutic target.

This application note will allow you to:

  • Get an overview of the liver fibrosis mechanism’s function and dynamics
  • Take advantage of HTRF technology to study the TGF-β/SMAD/α-SMA signaling axis
  • Benefit from additional content to help you revolutionize NASH discovery